INTRA-CELLULAR THERAPIES INC. - COMMON STOCK

Intra-Cellular Therapies to Present at the 22nd Annual Needham Virtual Healthcare Conference

11 апр 2023 08:00:35 Источник Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces Positive Topline Results from Study 403 Evaluating Lumateperone as Monotherapy in Patients with Major Depressive Disorder with Mixed Features and Bipolar Depression with Mixed Features

28 мар 2023 07:00:12 Источник Nasdaq GlobeNewswire

Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate Update

01 мар 2023 07:30:35 Источник Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast

14 фев 2023 08:00:33 Источник Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the SVB Securities Global Biopharma Conference

08 фев 2023 08:00:59 Источник Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the 41st Annual J.P. Morgan Healthcare Conference

03 янв 2023 08:00:24 Источник Nasdaq GlobeNewswire

Intra-Cellular Therapies Highlights New CAPLYTA Bipolar Depression Data Presentations at the American College of Neuropsychopharmacology 61st Annual Meeting

08 дек 2022 08:00:01 Источник Nasdaq GlobeNewswire

Intra-Cellular Therapies to Participate at Two Upcoming Investor Conferences

10 ноя 2022 08:00:03 Источник Nasdaq GlobeNewswire

Intra-Cellular Therapies Reports Third Quarter 2022 Financial Results and Provides Corporate Update

03 ноя 2022 07:30:00 Источник Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host Third Quarter 2022 Financial Results Conference Call and Webcast

27 окт 2022 08:00:01 Источник Nasdaq GlobeNewswire

Intra-Cellular Therapies Reports Second Quarter 2022 Financial Results and Provides Corporate Update

09 авг 2022 07:30:00 Источник Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host Second Quarter 2022 Financial Results Conference Call and Webcast

02 авг 2022 08:00:01 Источник Nasdaq GlobeNewswire

Intra-Cellular Therapies Highlights Lumateperone Bipolar Depression Data Presentations at the 2022 International Society for Bipolar Disorders (ISBD) Experience

13 июн 2022 08:00:01 Источник Nasdaq GlobeNewswire

Intra-Cellular Therapies Reports First Quarter 2022 Financial Results and Provides Corporate Update

10 май 2022 07:30:01 Источник Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host First Quarter 2022 Financial Results Conference Call and Webcast

03 май 2022 08:00:01 Источник Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces FDA Approval of New Dosage Strengths for CAPLYTA® (lumateperone) for Specific Patient Populations

25 апр 2022 07:00:01 Источник Nasdaq GlobeNewswire

Intra-Cellular Therapies Announces Appointment of E. Rene Salas to Board of Directors

21 апр 2022 08:00:02 Источник Nasdaq GlobeNewswire

Intra-Cellular Therapies to Present at the 21st Annual Needham Virtual Healthcare Conference

05 апр 2022 08:00:03 Источник Nasdaq GlobeNewswire

Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update

01 мар 2022 07:30:00 Источник Nasdaq GlobeNewswire

Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call and Webcast

22 фев 2022 08:00:02 Источник Nasdaq GlobeNewswire